Position
Chief Medical Officer
Company
Verastem Oncology
NeedhamBiotechnologyHealthcareHealth CareTherapeuticsBiopharmaDescription
Verastem Oncology has announced the appointment of John Hayslip, MD as chief medical officer. Dr Hayslip brings extensive experience in oncology and research and development across industry and academia, and will lead the company’s clinical and medical strategy.
Quick answer
Verastem Oncology Appoints John Hayslip, M.D. as Chief Medical Officer (April 18, 2024). Verastem Oncology is based in Needham, Massachusetts, United States.
- Who is the new Chief Medical Officer at Verastem Oncology?
- Verastem Oncology named John Hayslip Chief Medical Officer, announced April 18, 2024.
- What did Verastem Oncology announce on April 18, 2024?
- Verastem Oncology has announced the appointment of John Hayslip, MD as chief medical officer. Dr Hayslip brings extensive experience in oncology and research and development across industry and academia, and will lead the company’s clinical and medical strategy.
- What does Verastem Oncology do?
- Verastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK...
- Where is Verastem Oncology based?
- Verastem Oncology is based in Needham, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Nuvation Bio (March 28, 2024), Madrigal Pharmaceuticals (March 11, 2024), Crinetics Pharmaceuticals (May 30, 2024) and Recursion Pharmaceuticals (April 19, 2024) also announced leadership changes within 45 days of Verastem Oncology.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Nuvation Bio Appoints Colleen Sjogren as Chief Commercial Officer (March 28, 2024)
- Madrigal Pharmaceuticals Appoints Mardi C. Dier as Senior Vice President and Chief Financial Officer (March 11, 2024)
- Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D. as Senior Vice President of Medical Affairs (May 30, 2024)
- Recursion Pharmaceuticals Appoints Najat Khan as Chief Commercial Officer and Head of R&D (April 19, 2024)
- Terns Pharmaceuticals, Inc. Appoints Melita Sun Jung as Chief Business Officer (April 10, 2024)
- Xencor Appoints Bart Cornelissen as Senior Vice President and Chief Financial Officer (April 9, 2024)
Who to call at Verastem Oncology, and when
A new leader at Verastem Oncology brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Verastem Oncology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Verastem Oncology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Verastem Oncology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Verastem Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Verastem Oncology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.